Global benchmarking company STEM Healthcare (STEM) is pleased to announce the appointment of Tim Missey as US President effective June 4th 2018.

Tim joins STEM from Mallinckrodt Pharmaceuticals where he was the General Manager for Neurology and prior to that, General Manager for Intrathecal Therapies.

Commenting on his new role, Tim said, “I’m delighted to be joining STEM at such an exciting time for both the business and the industry.  STEM has built a strong reputation in the market supported by the quality of their people and the services it provides.  I’m very much looking forward to leading the next phase of growth in the US.”

Tim will assume leadership responsibility for STEM US from Jason McKenna following his recent promotion to Global CEO designate.  Jason has been with STEM since 2008 and has held a variety of US and International roles throughout his career.

Jason said, “I’m excited to welcome Tim to STEM.  Tim joins us at a pivotal time given the opportunities to drive continued growth of our business.  His experience and perspective will be extremely valuable and I look forward to seeing the impact he will have in the US.”